Cholecystitis Clinical Trial
Official title:
Three-port Versus Four-port Laparoscopic Cholecystectomy: A Prospective Comparative Study
Various modifications have been tried in laparoscopic cholecystectomy since its introduction. One, two and three port LC have been performed on limited scale. we aim to compare three port LC with four port LC in patients with cholelithiasis. The main objective of this study is to evaluate the outcome of 3 ports LC for treatment of cholelithiasis by comparing the result with 4 ports LC with respect to safety and efficacy.
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | December 20, 2023 |
Est. primary completion date | December 30, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 25 Years to 65 Years |
Eligibility |
Inclusion Criteria: 1. Age of patient between 25 and 65 years 2. Diagnosis of chronic cholecystitis, symptomatic cholelithiasis Exclusion Criteria: 1. Choledocholithiasis 2. Severe Acute Calculus Pancreatitis 3. Severe co-morbid conditions (uncontrolled diabetes, Hypertension, severe direct hyper bilirubinemia) 4 . Previous operation or adhesion |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Mühe E. [Laparoscopic cholecystectomy--late results]. Langenbecks Arch Chir Suppl Kongressbd. 1991:416-23. Review. German. — View Citation
Traverso LW. Carl Langenbuch and the first cholecystectomy. Am J Surg. 1976 Jul;132(1):81-2. — View Citation
Trichak S. Three-port vs standard four-port laparoscopic cholecystectomy. Surg Endosc. 2003 Sep;17(9):1434-6. Epub 2003 Jun 13. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | compare between the prognosis of three port and four port laproscpic cholecyctectomy | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT03636841 -
Reduction of Operating Time by a Smoke Electroprecipitation Device for Acute Cholecystitis
|
N/A | |
Completed |
NCT02379780 -
Ultrasound Guided Subcostal Transversus Abdominis Plane Versus Paravertebral Block in the Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT02264444 -
Establishing Visualization Grading Scale on LESS Cholecystectomy
|
N/A | |
Completed |
NCT02461147 -
Prospective Validation of "Cholecystectomy First" Strategy for Gallstone Migration
|
||
Completed |
NCT01937104 -
ONSD According to the Position During Laparoscopy
|
N/A | |
Completed |
NCT01476995 -
Prognostic Indicators as Provided by the EPIC ClearView
|
N/A | |
Completed |
NCT00940264 -
Laparoscopic Transvaginal Hybrid Cholecystectomy: a Prospective Data Collection.
|
N/A | |
Completed |
NCT00746850 -
Harmonic in Laparoscopic Cholecystectomy for Acute Cholecystitis
|
N/A | |
Completed |
NCT00370344 -
Small-incision Open Cholecystectomy or Laparoscopic Cholecystectomy for Gallbladder Disease
|
Phase 2/Phase 3 | |
Completed |
NCT00195351 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection
|
Phase 4 | |
Completed |
NCT02858986 -
3D Versus 4K Laparoscopic Cholecystectomy
|
N/A | |
Completed |
NCT04602156 -
US-guided Trocar Versus Seldiger Technique for Percutaneous Cholecystostomy
|
N/A | |
Completed |
NCT04942665 -
Low Dose ICG for Biliary Tract and Tumor Imaging
|
Phase 2 | |
Completed |
NCT02547064 -
Effect of Modified Stylet Angulation on the Intubation With GlideScope®
|
N/A | |
Completed |
NCT00230971 -
Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)
|
Phase 4 | |
Completed |
NCT04122261 -
A Clinical Study of Chinese Domestic Surgical Robot
|
N/A | |
Completed |
NCT04716166 -
Incentive Spirometry and Upper Abdominal Laparoscopic Surgery
|
N/A | |
Completed |
NCT01476319 -
Improving Informed Consent Process for Percutaneous Cholecystostomy in the Emergency Department
|
N/A | |
Withdrawn |
NCT02225418 -
Transmuscular Quadratus Lumborum Block for Laparoscopic Cholecystectomy
|
N/A | |
Suspended |
NCT04306939 -
Genomic Resources for Enhancing Available Therapies (GREAT1.0) Study
|